SCHEMBL2201513

SCHEMBL2201513

O=C(NCC1COc2ccccc2O1)c1ccc(C(=O)C(F)(F)F)s1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.71
RAB9A P51151 5/20 0.71
TDP1 Q9NUW8 1/20 0.71
SMN1; SMN2 Q16637 3/20 0.60
HPGD P15428 3/20 0.60
MTNR1A P48039 1/20 0.56
TSHR P16473 2/20 0.56
HDAC4 P56524 4/20 0.55
HDAC1 Q13547 4/20 0.55
HDAC6 Q9UBN7 4/20 0.55
HDAC3 O15379 3/20 0.55
MAPK1 P28482 1/20 0.53
POLB P06746 1/20 0.53
ALDH1A1 P00352 3/20 0.51
AIMP2 Q13155 2/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.51
GLA P06280 1/20 0.51
ALOX12 P18054 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2204276 0.74 HDAC4 (0.66) NPC1RAB9ASMN1; SMN2HPGDHDAC4
SCHEMBL2205079 0.74 HDAC6 (0.87) HDAC4HDAC1HDAC6HDAC3CYP2C9
SCHEMBL22393113 0.74 HPGD (0.76) NPC1RAB9ASMN1; SMN2HPGDMTNR1A
SCHEMBL1567604 0.74 MTNR1A (0.76) NPC1RAB9ATDP1SMN1; SMN2HPGD
SCHEMBL2299549 0.73 NPC1 (0.64) NPC1RAB9ATDP1SMN1; SMN2HPGD
SCHEMBL7202212 0.73 MTNR1A (1.00) NPC1RAB9ASMN1; SMN2HPGDMTNR1A
SCHEMBL17707638 0.72 F10 (0.52) HDAC4HDAC1HDAC6HDAC3
SCHEMBL2233258 0.72 HDAC6 (0.70) HDAC4HDAC1HDAC6HDAC3
SCHEMBL19652069 0.72 MTNR1A (0.72) NPC1RAB9ASMN1; SMN2HPGDMTNR1A
SCHEMBL21589939 0.72 USP2 (0.78) NPC1RAB9ATDP1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP claimed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 NPC1 657/4885RAB9A 2693/4885TDP1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.